501 related articles for article (PubMed ID: 27571006)
1. Medical Therapy in Chronic Thromboembolic Pulmonary Hypertension.
Pepke-Zaba J; Jais X; Channick R
Ann Am Thorac Soc; 2016 Jul; 13 Suppl 3():S248-54. PubMed ID: 27571006
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological therapy for patients with chronic thromboembolic pulmonary hypertension.
Hoeper MM
Eur Respir Rev; 2015 Jun; 24(136):272-82. PubMed ID: 26028639
[TBL] [Abstract][Full Text] [Related]
3. Advances in targeted therapy for chronic thromboembolic pulmonary hypertension.
Zhang Y; Yu X; Jin Q; Luo Q; Zhao Z; Zhao Q; Yan L; Liu Z
Heart Fail Rev; 2019 Nov; 24(6):949-965. PubMed ID: 31044326
[TBL] [Abstract][Full Text] [Related]
4. Chronic thromboembolic pulmonary hypertension.
Hoeper MM; Madani MM; Nakanishi N; Meyer B; Cebotari S; Rubin LJ
Lancet Respir Med; 2014 Jul; 2(7):573-82. PubMed ID: 24898750
[TBL] [Abstract][Full Text] [Related]
5. Developments in pulmonary arterial hypertension-targeted therapy for chronic thromboembolic pulmonary hypertension.
Hadinnapola C; Pepke-Zaba J
Expert Rev Respir Med; 2015 Oct; 9(5):559-69. PubMed ID: 26366805
[TBL] [Abstract][Full Text] [Related]
6. Recent progress in the diagnosis and management of chronic thromboembolic pulmonary hypertension.
Tanabe N; Sugiura T; Tatsumi K
Respir Investig; 2013 Sep; 51(3):134-46. PubMed ID: 23978639
[TBL] [Abstract][Full Text] [Related]
7. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.
Jaïs X; D'Armini AM; Jansa P; Torbicki A; Delcroix M; Ghofrani HA; Hoeper MM; Lang IM; Mayer E; Pepke-Zaba J; Perchenet L; Morganti A; Simonneau G; Rubin LJ;
J Am Coll Cardiol; 2008 Dec; 52(25):2127-34. PubMed ID: 19095129
[TBL] [Abstract][Full Text] [Related]
8. Riociguat: a review of its use in patients with chronic thromboembolic pulmonary hypertension or pulmonary arterial hypertension.
Garnock-Jones KP
Drugs; 2014 Nov; 74(17):2065-78. PubMed ID: 25352393
[TBL] [Abstract][Full Text] [Related]
9. Riociguat for the treatment of pulmonary hypertension.
Meis T; Behr J
Expert Opin Pharmacother; 2014 Nov; 15(16):2419-27. PubMed ID: 25260791
[TBL] [Abstract][Full Text] [Related]
10. Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension.
Kim NH; D'Armini AM; Grimminger F; Grünig E; Hoeper MM; Jansa P; Mayer E; Neurohr C; Simonneau G; Torbicki A; Wang C; Fritsch A; Davie N; Ghofrani HA
Heart; 2017 Apr; 103(8):599-606. PubMed ID: 28011757
[TBL] [Abstract][Full Text] [Related]
11. Riociguat: a novel therapeutic option for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Mielniczuk LM; Swiston JR; Mehta S
Can J Cardiol; 2014 Oct; 30(10):1233-40. PubMed ID: 25154043
[TBL] [Abstract][Full Text] [Related]
12. Chronic thromboembolic pulmonary hypertension: role of medical therapy.
Pepke-Zaba J; Jansa P; Kim NH; Naeije R; Simonneau G
Eur Respir J; 2013 Apr; 41(4):985-90. PubMed ID: 23397304
[TBL] [Abstract][Full Text] [Related]
13. Riociguat: an upcoming therapy in chronic thromboembolic pulmonary hypertension?
Kim NH
Eur Respir Rev; 2010 Mar; 19(115):68-71. PubMed ID: 20956169
[TBL] [Abstract][Full Text] [Related]
14. Bosentan or Macitentan Therapy in Chronic Thromboembolic Pulmonary Hypertension?
van Thor MCJ; Ten Klooster L; Snijder RJ; Kelder JC; Mager JJ; Post MC
Lung; 2019 Dec; 197(6):753-760. PubMed ID: 31583452
[TBL] [Abstract][Full Text] [Related]
15. Is distal chronic thromboembolic pulmonary hypertension treatable with PAH targeted drugs?
Cannon JE; Pepke-Zaba J
Semin Respir Crit Care Med; 2013 Oct; 34(5):620-6. PubMed ID: 24037629
[TBL] [Abstract][Full Text] [Related]
16. Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry.
Ghofrani HA; Gomez Sanchez MA; Humbert M; Pittrow D; Simonneau G; Gall H; Grünig E; Klose H; Halank M; Langleben D; Snijder RJ; Escribano Subias P; Mielniczuk LM; Lange TJ; Vachiéry JL; Wirtz H; Helmersen DS; Tsangaris I; Barberá JA; Pepke-Zaba J; Boonstra A; Rosenkranz S; Ulrich S; Steringer-Mascherbauer R; Delcroix M; Jansa P; Šimková I; Giannakoulas G; Klotsche J; Williams E; Meier C; Hoeper MM;
Respir Med; 2021 Mar; 178():106220. PubMed ID: 33540340
[TBL] [Abstract][Full Text] [Related]
17. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
Ikeda N
Cardiovasc Interv Ther; 2020 Apr; 35(2):130-141. PubMed ID: 31873853
[TBL] [Abstract][Full Text] [Related]
18. Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Bishop BM
Am J Health Syst Pharm; 2014 Nov; 71(21):1839-44. PubMed ID: 25320133
[TBL] [Abstract][Full Text] [Related]
19. Perspectives on oral pulmonary hypertension therapies recently approved by the U.S. Food and Drug Administration.
Hill NS; Badesch D; Benza RL; D'Eletto TA; Farber HW; Gomberg-Maitland M; Hassoun PM; Preston I
Ann Am Thorac Soc; 2015 Feb; 12(2):269-73. PubMed ID: 25590376
[TBL] [Abstract][Full Text] [Related]
20. Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension.
Lian TY; Jiang X; Jing ZC
Drug Des Devel Ther; 2017; 11():1195-1207. PubMed ID: 28458514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
